| Entry |
|
|---|
| Name |
Pegteograstim (INN) |
|---|
| Sequence |
MTPLGPASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
QMEELGMAPA LQPTQGCAMP AFASAFQRRA GGVLVASHLQ SFLEVSYRVL RHLAQP
(Disulfide bridge: 37-43, 65-75) |
|---|
| Type |
Peptide |
|---|
| Class |
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineutropenic, Granulocyte colony stimulating factor (G-CSF) |
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA17 Pegteograstim
D11026 Pegteograstim (INN)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
D11026 Pegteograstim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D11026 Pegteograstim (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
